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Abstract
Background: Perivenular inflammation is a common early pathological feature in multiple sclerosis (MS). A recent
hypothesis stated that CNS inflammation is induced by perivenular iron deposits that occur in response to altered
blood flow in MS subjects. In order to evaluate this hypothesis, an animal model was developed, called cerebral
experimental autoimmune encephalomyelitis (cEAE), which presents with CNS perivascular iron deposits. This
model was used to investigate the relationship of iron deposition to inflammation.
Methods: In order to generate cEAE, mice were given an encephalitogen injection followed by a stereotactic
intracerebral injection of TNF-a and IFN-g. Control animals received encephalitogen followed by an intracerebral
injection of saline, or no encephalitogen plus an intracerebral injection of saline or cytokines. Laser Doppler was
used to measure cerebral blood flow. MRI and iron histochemistry were used to localize iron deposits. Additional
histological procedures were used to localize inflammatory cell infiltrates, microgliosis and astrogliosis.
Results: Doppler analysis revealed that cEAE mice had a reduction in cerebral blood flow compared to controls.
MRI revealed T2 hypointense areas in cEAE animals that spatially correlated with iron deposition around vessels
and at some sites of inflammation as detected by iron histochemistry. Vessels with associated iron deposits were
distributed across both hemispheres. Mice with cEAE had more iron-labeled vessels compared to controls, but
these vessels were not commonly associated with inflammatory cell infiltrates. Some iron-laden vessels had
associated microgliosis that was above the background microglial response, and iron deposits were observed
within reactive microglia. Vessels with associated astrogliosis were more commonly observed without colocalization
of iron deposits.
Conclusion: The findings indicate that iron deposition around vessels can occur independently of inflammation
providing evidence against the hypothesis that iron deposits account for inflammatory cell infiltrates observed in MS.
Background
Recent studies suggest a possible link between iron
deposition around vessels, poor venular blood flow and
perivascular inflammation in the CNS of multiple
sclerosis (MS) subjects [1-4]. Perivascular iron deposits
have been observed both histologically [5] and by MRI
susceptibility weighted imaging (SWI) [6,7]. One pro-
posed explanation for these iron deposits is the
extravasation of red blood cells (RBCs) across the BBB
and their subsequent phagocytosis by macrophages
[5,7]. In addition, altered blood flow has been observed
both intracranially [1,2,4] and extracranially [3] in MS
subjects. Extracranial vessel stenosis has been hypothe-
sized to explain the disturbed blood flow, and the
altered blood flow has been hypothesized to induce the
extravasation of RBCs resulting in iron deposits that
trigger inflammatory changes in the CNS [3,4,8-11].
However, alternative explanations could account for
these observations. For example, altered blood flow
could result from vessel congestion or occlusion due to
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inflammatory cells, fibrin deposits, or other factors
within the brain [5,12-14], and iron deposits could
develop as a consequence of inflammatory reactions
rather than inducing these pathological events.
Inflammatory cell infiltrates located around CNS veins
are a recurring pathological characteristic observed in
MS, particularly relapsing remitting MS [12,15,16].
Despite these observations it is unknown whether iron
deposition, reduced blood flow, and perivascular inflam-
mation are interrelated. A useful way to address the
interrelationship is through the study of an animal
model of MS that enables systematic analyses at differ-
ent stages of disease development. While there are
many animal models of MS [17], very few consistently
develop lesions in the cerebrum, which is the principal
site where iron deposits have been described in MS
[5,7-9,18-20]. One objective of the present study was to
develop an animal model that generates cerebral pathol-
ogy, in particular, iron deposits and vessel changes simi-
lar to those present in MS. A second objective was to
utilize this model to address the interrelationship of iron




All studies involving the use of animals were approved
by the Institutional Animal Care and Use Committee of
the University of Kansas Medical Center. EAE was
induced in 5-6 week old female SJL mice (Jackson
Laboratory, Bar Harbor, ME) as previously described
[21] with the exception of using a half dose of encepha-
litogen. The encephalitogen peptide, proteolipid protein
(PLP) amino acids 139-151, was suspended in saline and
emulsified in an equal volume of Freund’s incomplete
adjuvant containing M. tuberculosis H37RA. Briefly,
female SJL mice were anesthetized with avertin and
given a total dose of 75 μg PLP peptide with 150 μg M.
tuberculosis that was divided into 3 s.c. injections on the
dorsum. A tail vein injection of pertussis toxin (0.1 μg
in 50 μl) was given on 0, 3, and 7 days post encephalito-
gen injection. Mice received food and water ad libitum.
At 8-11 days post encephalitogen injection, mice were
anesthetized with avertin, prepped for surgery, given a
craniotomy, and administered an intracerebral injection
using a pulled glass pipette. The injection site was x =
2.0, y = -0.46, z = -1.8 mm relative to Bregma. The
injection was given over 4 min using a Nanomite Injec-
tor Syringe Pump (Harvard Apparatus, Holliston, MA).
Similar to a localized lesion EAE rat model [22], the
injection consisted of TNF-a (250 ng) and IFN-g (15
ng) (R&D Systems) in 2 μl. The control groups were: 1)
no encephalitogen injection but given pertussis toxin
injections + intracerebral injection of saline (NonEAE,
saline); 2) no encephalitogen injection but given pertus-
sis toxin injections + intracerebral injection of cytokines
(NonEAE, cytokine); and 3) encephalitogen injection
with pertussis toxin injections + intracerebral injection
of saline (EAE, saline).
MRI
Five cEAE mice were selected for MRI at either 4 or 21-
23 days following the intracerebral injection. The MR
imaging was performed on a 9.4 Tesla MR system,
which had a Varian INOVA console (Varian Inc., Palo
Alto, CA), and gradient coils (40 G/cm, 250 μs) of 12
cm in diameter (Magnex Scientific, Abingdon, UK).
Anesthesia was induced with 4% isoflurane and main-
tained at 1%-2%. A quadrature RF surface coil was
placed on top of the animal head to acquire T2-
weighted spin-echo images with the following imaging
parameters: TE/TR = 30/1500 ms, matrix size = 192 ×
192, field of view = 12.8 × 12.8 mm, slice thickness =
0.2 mm, and number of averages = 6. The correspond-
ing nominal image resolution was 67 × 67 × 200 μm.
Iron histochemistry
At 4 or 21-23 days after the stereotactic injection, mice
were anesthetized with isoflurane and perfused with sal-
ine followed by 10% buffered formalin (Fisher Scientific,
Waltham, MA). These time points were selected since
they represented periods of primary (Day 4) and second-
ary (Day 21-23) waves of inflammation and clinical
signs. Brains were post-fixed overnight at 4°C and trans-
ferred to a cryoprotectant solution, 25% glycerol and
2.5% DMSO in PBS. Brains were embedded in 10% gela-
tin in cryoprotectant solution and cross linked with 10%
buffered neutral formalin in cryoprotectant solution for
48 h. Coronal sections, 50 μm thick, were prepared with
a microtome, stored in 50% ethylene glycol and 1% (w/
v) polyvinyl pyrrolidone in PBS at -20°C. Sections were
stained by iron histochemistry as described previously
[23]. Briefly, sections were rinsed with PBS and incu-
bated for 30 min at room temperature with a 1:2:1 ratio
of 4% potassium ferrocyanide, 2% Triton X-100, and 0.5
N HCl respectively. The sections were then washed in
PBS and incubated for 12-15 min in 0.2 mg DAB per
ml of 0.01 M Tris-HCl, pH 7.4, with 0.06% H2O2. Sec-
tions were rinsed in PBS, immersed in a gelatin solution
and mounted on a slide before being dehydrated and
cover slipped using Permount (Fisher Scientific).
Vessel measurements
All descending cortical vessels, perpendicular to the pial
surface, were counted in a blinded manner, and vessel
diameters were measured using Neurolucida (MBF
Bioscience, Williston, VT). The ratio of iron stained to
unstained vessels and the percent of iron stained vessels
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with a diameter > 40 μm were determined by averaging
data collected from three sections per animal.
Iron histochemistry and GFAP immunohistochemistry
Following iron histochemical staining, sections were
incubated in blocking solution [98% Superblock (Pierce,
Rockford, IL), 2% normal goat serum (Vector Labora-
tories, Inc., Burlingame, CA)] for 1 h, PBS 3 × 5 min,
1:5,000 rabbit anti-GFAP (Cat. No. Z0334; Dako North
America, Inc., Carpinteria, CA) in 10% blocking solution
in PBS for 1 h, PBS 3 × 5 min, 1:500 biotinylated goat
anti-rabbit IgG (Vector) in 10% blocking solution for 1
h, PBS 3 × 5 min, Vectastain Elite ABC for 30 min, PBS
3 × 5 min, SG Peroxidase Substrate Kit (Vector) for 10
min, H2O, mounted on slides with gelatin, stained with
hematoxylin, and dehydrated through xylenes.
For each animal, two sections between Bregma -0.70
and -2.00 were analyzed by an evaluator blinded to the
animal’s group. The somatosensory 1 barrel field/second-
ary somatosensory cortex on both hemispheres were
evaluated for numbers of descending cortical vessels and
whether or not they had gliosis, associated inflammatory
cells and/or iron staining. Vessel-associated gliosis was
defined as ≥2 astrocyte processes, abutting or adjacent to
a vessel with the processes within 50 μm of each other,
and the processes had at least one of the following char-
acteristics: 1) an image analysis density reading of ≥150
(ImageJ, NIH), or 2) a diameter of at least 0.9 μm. A posi-
tive inflammatory response was defined as ≥4 inflamma-
tory cells associated with a vessel while iron deposition
was defined as brown staining associated with a vessel.
Iron histochemistry and anti-Iba-1 immunohistochemistry
Following iron histochemical staining, sections were
incubated in blocking solution for 1 h, PBS 3 × 5 min,
1:2,000 rabbit anti-ionized calcium binding adaptor
molecule (Iba-1) (Cat. No. 019-19741; Wako Pure Che-
mical Industries, Ltd., Chuo-ku, Osaka, Japan) in 10%
blocking solution in PBS for 1 h. Subsequent steps were
equivalent to those described for GFAP staining except
sections were not counterstained with hematoxylin.
For each animal, one section between Bregma -1.30
and -2.00 was evaluated. An evaluator, blinded to the
animal grouping, took a picture of the somatosensory 1
barrel field cortex area with maximal Iba-1 staining
from each hemisphere using a 20 × objective. The hemi-
sphere with the greater staining was identified by visual
inspection, and the rank order of staining density for all
animals was determined independently from two addi-
tional evaluators blinded to the animals’ grouping.
Cerebral Surface Blood Flow
Animals were anesthetized with isoflurane, the skull was
exposed, and mice were placed under a moorLDI Laser
Doppler scanner (Moore Instruments, Axminster, UK).
The distance of the laser to the skull surface and the
surface area scanned, 44 mm2 covering 2,772 pixels,
were kept constant between animals. The scans were
analyzed by the ImageJ histogram function, wherein
each pixel was assigned a color that represented relative
flow. The colors were categorized into 16 different bins
which were separated by equal intervals of velocities,
except for the first and last bins, which included the
maximum and minimum limits of detection, respec-
tively. Total blood flow in the cranial surface area per
animal was determined by multiplying pixel numbers by
their rank and summing the results from all bins.
Statistics
Cerebral surface blood flow and astrocyte gliosis data
were evaluated using the Student’s T-test while counts
of unstained and stained vessels following iron histo-
chemistry, diameters of iron stained vessels, and rank
ordering of microgliosis staining were evaluated using
the Wilcoxon test.
Results
MRI T2 hypointense regions
In mice with cEAE, MRI revealed abnormal T2 hypoin-
tense regions at the injection site and in areas remote
from the injection site, e.g., in the opposite cerebral
hemisphere (Figure 1). The abnormal T2 hypointense
sites were present in the subcortical white matter and
distributed throughout the cerebral cortex. Hypointense
areas in the cortex often revealed a column perpendicu-
lar to the cortical surface with a pattern following that
for descending cortical vessels.
Distribution of abnormal iron deposits
The spatial distribution of pathological iron deposits
aligned with the distribution of the abnormal T2
hypointense areas (Figure 1). Iron deposits were
observed within inflammatory cells in the subcortical
white matter (Figure 1), lining blood vessels in the cor-
tex (Figures 1, 2), dispersed in the neuropil, and in cells
surrounding the vessels (Figure 2B) in both hemi-
spheres. Iron labeled cells surrounding vessels were
positive for Iba-1, a marker of microglia (discussed
below). In addition, extravasation of RBCs was also
occasionally observed (not shown).
Iron labeled blood vessels
Mice with cEAE had more iron stained vessels than con-
trol groups at both 4 and 21-23 days after the intracerebral
injection (Figure 2C). Furthermore, the diameter of the
iron stained vessels was increased in cEAE mice compared
to the NonEAE saline control animals at Day 21-23, but
not at Day 4 (Figure 2D). The majority of iron labeled
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vessels were not associated with inflammatory cells (Figure
3B), although inflammatory cells around vessels could be
associated with (Figure 3A) or independent of (not shown)
iron labeling of vessels in cEAE mice.
Cerebral blood flow
Compared to NonEAE saline controls, mice with cEAE
had significantly reduced cerebral blood flow (Figure
3D), which could be due to vessel congestion caused by
inflammatory cells (Figure 3C). Increases in vessel dia-
meter (Figure 2D) could also reflect consequences of
vessel congestion.
Perivascular microglial reactions
Iba-1 immunohistochemistry labeled reactive microglia
with minimal background staining. Microgliotic reac-
tions were present in both gray and white matter
regions in both hemispheres and were often associated
with vessels, but were not limited to these structures.
Reactive microglia were more pronounced in mice with
cEAE than in NonEAE saline control animals (not
shown). Microgliotic reactions around vessels could be
associated with iron deposits (Figure 4C), which were
often localized within reactive microglia (Figure 4D), or
microgliosis could be independent of iron deposits (Fig-
ure 4A). Alternatively, iron deposits around vessels
could be independent of microgliosis (Figure 4B).
Perivascular astrocyte reactions
GFAP immunohistochemical staining revealed astrocyte
gliosis in both gray and white matter structures in both
hemispheres, and these reactions were often associated
with vessels. Astrogliosis around vessels could be asso-
ciated with (Figure 5A) or independent of (Figure 5B)
iron deposition, in fact, the later was more common
(Figure 5D). However, when gliosis was associated with
iron deposits, it was more abundant in mice with cEAE
compared to NonEAE saline controls at 4 and 21-23
days. In addition, iron deposits around vessels could
occur independent of astrocyte gliosis (Figure 5C).
Discussion
Perivenular pathology, such as the breakdown of the
BBB, perivascular infiltration of inflammatory cells into
Figure 1 Colocalization of T2 hypointense areas and iron deposits. (A) MRI reveals an abnormal T2 hypointensity in the ipsilateral
subcortical white matter (WM) (beneath the star) relative to the injection. Additional hypointense structures perpendicular to the pial surface
(arrows) were present in the contralateral hemisphere. (B) Iron histochemical staining reveals iron deposits that colocalize with T2 hypointensities
observed in A. The region beneath the star indicates an area of subcortical WM with labeling in inflammatory cells, around vessels, within
microglia and generally throughout the region. The arrows indicate labeling around descending vessels that extend towards the subcortical WM.
(C) A more posterior slice from A. T2 hypointense areas are seen in the contralateral subcortical WM (e.g., arrowhead) and in a perpendicular
structure that follows the pattern of a descending cortical vessel (arrow). (D) Iron histochemical staining reveals a colocalization of iron deposits
and T2 hypointense areas observed in C. (E, F) Higher magnifications of stained areas observed in D (note, arrows and arrowheads label
equivalent structures in C-F). Staining around vessels occurred in endothelial cells, macrophages/microglia and/or neuropil. Bar = 1 mm for A-D.
Bar in F = ~175 μm for E; ~50 μm for F.
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Figure 2 Iron stained blood vessels are prevalent in cEAE. (A) Control NonEAE Saline animals demonstrated little to no iron staining in the
cortex. (B) cEAE animals revealed iron staining associated with vessels in the cortex. Staining was localized to the lining of vessels, the
surrounding neuropil, and macrophages/microglia. Bars in A and B = 50 μm. (C) At both Day 4 and Day 22 (range 21-23) cEAE animals
demonstrated a significantly higher ratio of iron stained vessels to unstained vessels as compared to NonEAE Saline animals. (D) At Day 22
(range 21-23) the mean percent of stained vessels in cEAE animals had a greater diameter than control NonEAE Saline animals (note, the bar
slightly above 0, without an error bar, indicates analysis of tissue in this group of animals, but no labeled vessels were > 40 μm). Error bars =
SEM. N = 6 for all groups, except cEAE Day 4 (N = 5). **p ≤ 0.01.
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the CNS, and perivenous demyelination are consistently
identified in MS [12,14-16,24]. Despite these observa-
tions, a broader understanding of the contribution of
vascular changes to the overall disease course has been
lacking. Some studies suggest that MS patients suffer
from extracranial vascular stenosis that affects blood
flow patterns and CNS vessel drainage [3,4,8,11]; how-
ever, recent studies have raised doubts about these find-
ings [25,26]. A hypothesis that linked observations on
venous reflux to the generation of perivenular iron
deposits [4,8,9,27], also proposed that the source of peri-
venular iron deposits is extravasated RBCs that occur as
a consequence to alterations in blood flow patterns
resulting in micro bleeds. The perivenular iron deposits
were hypothesized to stimulate the infiltration of inflam-
matory cells into the CNS that induce subsequent
pathological changes that are associated with MS, e.g.,
demyelination [4,8-10].
In order to test whether iron deposits initiate the
inflammatory events that develop in MS, it is necessary
to study the early stages of disease pathogenesis. How-
ever, these stages are difficult to study in humans due to
the delay between the onset of symptoms and diagnosis,
and the inability to obtain tissue specimens. EAE has
been a useful tool for analyzing immune responses, test-
ing potential therapeutics, and studying the development
Figure 3 Vascular changes in cEAE mice. (A) A vessel with both inflammatory cells and iron staining. Bar = 50 μm. (B) The average number of
vessels stained positive for iron with or without inflammation was significantly higher in cEAE mice than NonEAE Saline controls (note, bars
slightly above 0, without error bars, indicate analyses of tissues in these groups of animals, but no iron stained vessels were observed). Also, the
iron laden vessels without inflammation were significantly more abundant than iron laden vessels associated with inflammation. (C) A vessel
from a cEAE mouse is congested with inflammatory cells as revealed by hematoxylin staining. Several iron labeled cells are also present in the
vessel lumen. Bar = 50 μm. (D) Blood flow was decreased in both Day 4 and Day 22 (range 21-23) cEAE mice compared to control NonEAE
Saline mice. Error bars = SEM. N = 6 animals per group, except Day 4 cEAE (N = 5). *p ≤ 0.05, **p ≤ 0.01.
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of pathology relevant to MS [17]. However, most EAE
models develop spinal cord and brain stem pathology
while cerebral pathology is limited and/or inconsistent.
Since the hypothesis attributing inflammation as a con-
sequence of iron deposition is largely based on analysis
of cerebral tissue [3-10,16,18,27], an EAE model that
consistently develops cerebral pathology is necessary to
evaluate this proposition. Thus, we developed the cEAE
model following the general approach used by Ker-
schensteiner and colleagues, i.e., an injection of cyto-
kines to direct the inflammatory response to a specific
CNS region [22]. This model reproduced many vessel-
associated pathological features that are seen in MS
including the accumulation of iron deposits around ves-
sels. In addition to lining vessels, iron deposits were
found in the surrounding neuropil, as extravasated
RBCs, and within reactive microglia and macrophages.
Although inflammatory cell infiltrates could be
associated with perivascular iron deposits, inflammatory
cells were also observed without associated iron depos-
its. This finding suggests that the development of
inflammatory cell infiltrates is not dependent on iron
deposition, which is in contrast to the hypothesis stating
that iron deposits induce the inflammatory cell response
that goes on to cause pathology such as demyelination.
Studies have shown the presence of iron accumulation
around blood vessels in MS subjects using iron histo-
chemistry [5,16,18] or MRI-SWI [6,7], but there has not
been a direct correlation on the same specimens. In
addition, T2 hypointense areas in gray matter structures
from MS patients have been inferred to be iron deposits
[28], but it has been difficult to establish a definitive
link between histochemical findings and MRI observa-
tions due to the lack of brain tissue, for histochemical
staining, from subjects who had an MRI just prior to
death. In the present study, MRI T2-hypointense areas
Figure 4 Microglial Iba-1 and iron histochemical double staining in cEAE mice. (A) Reactive microglia Iba-1 staining could be present
around vessels without associated iron deposits, or conversely, (B) iron staining could be present around vessels without associated microgliosis.
(C) An iron labeled vessel with associated microgliosis and double labeled cells revealing iron deposits within reactive microglia (arrowheads).
(D) Reactive microglial cells containing iron deposits (arrowheads). Bars = 50 μm.
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were compared with histochemical staining in the same
mouse brain. Colocalizations of T2 hypointense areas
and iron deposits were observed around blood vessels
and in subcortical white matter. Other studies have uti-
lized macrophages that were preloaded with exogenous
iron to detect their accumulation within the CNS by
MRI T2 hypointense areas in EAE subjects [29], but
here we show the accumulation of endogenous iron
deposits are colocalized to T2 hypointense areas.
In cEAE, pathological changes occurred rapidly after
the onset of disease and were not routinely present in
deep gray matter structures. Thus, these findings might
not be applicable for addressing the accumulation of
iron in deep gray matter structures in MS subjects that
appears to advance as a result of long-standing disease.
For example, iron deposition in deep gray matter
structures is more pronounced in secondary progressive
MS compared to relapsing remitting MS [28,30].
The presence of iron deposits around cerebral blood
vessels was observed predominately in mice with cEAE,
not in control groups. This indicates encephalitogenic
activation of inflammatory cells and their further entice-
ment by cytokines are required to initiate the vessel
pathology seen in the cerebrum in our model. Iron
deposits around cerebral vessels were also noted in
another demyelinating disease, the twitcher mouse
model of globoid cell leukodystrophy [31]. This disease
is due to a genetic mutation in the glactosylceramidase
gene, and thus, the accumulation of vessel associated
iron deposits is secondary to the underlying genetic
defect that results in demyelination. However, in addi-
tion to extensive demyelination, there are profound
Figure 5 GFAP, iron histochemical and hematoxylin staining. (A) In cEAE mice, iron staining around vessels could be associated with
astrocyte gliosis. On rare occasions, astrocytes were colabeled with iron (not shown). (B) In cEAE mice, GFAP staining around blood vessels
could be observed independent of iron deposits, and conversely, (C) iron staining around vessels could be observed independent of astrocyte
gliosis (note, the diminished density of dark blue astrocyte processes around the iron labeled vessel compared with A). Bar = 50 μm for A-C. (D)
For all types of stained vessels (GFAP + iron, GFAP alone, iron alone), there was more staining in the cEAE mice compared to the NonEAE Saline
controls, although the GFAP alone staining did not reach significance (note, bars slightly above 0 without error bars indicate analyses of tissues
in these groups of animals, but values were 0). Error bars = SEM. N = 6 animals per group, except Day 4 cEAE (N = 5). *p ≤ 0.05, **p ≤ 0.01.
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macrophage [32] and astrocyte gliotic [33] responses,
and there is an enhanced expression of proinflammatory
cytokines, e.g., TNF-a and IL-6 [34]. Thus, twitcher
mice, cEAE mice and MS subjects all display iron
deposits around vessels in conjuncture with the pre-
sence of proinflammatory cytokines [34-36] and acti-
vated inflammatory cells in the CNS [12,16]. Therefore,
it appears that inflammatory stimuli can induce iron
deposition around vessels independent of vessel stenosis.
This would allow for an alternate mechanism for the
development of iron deposition as put forward in the
hypothesis proposing that vessel stenosis is the cause of
perivenular iron deposits in brains of MS subjects.
Both astrogliosis and microgliosis were present in the
brains of cEAE mice, and iron deposits were colocalized
within microglia. However, iron deposits were not
required for the development of astrogliosis and micro-
gliosis around vessels since these reactions could be
observed in the absence of perivascular iron deposits. On
occasion, perivascular iron deposits appeared to induce a
localized microgliotic reaction that was greater than that
observed in the neighboring tissue (Figure 4C). It appears
that these localized reactions were in response to extracel-
lular iron deposits, such as those resulting from RBCs
extravasation, but we cannot eliminate other types of iron
deposits, e.g., those within endothelial or microglial cells.
Other studies have shown that microglia cultured in the
presence of excess iron have enhanced effector functions,
increased NF-B activity, and increased release of pro-
inflammatory cytokines [37-40]. Since iron is taken up by
perivascular microglia/macrophages in MS and EAE
[5,12,18,20], it is possible that iron deposits could amplify
pathogenesis via these cells. Iron deposits could also pro-
mote disease activity by acting as a catalyst in the produc-
tion of reactive oxygen species, which have been
implicated in disease progression of MS and EAE [41].
Disturbances to cerebral blood flow were observed in
mice with cEAE. Altered blood flow has also been
observed in MS by MRI [1,2] and in EAE [42]. In cEAE,
we have observed vessel congestion, e.g., inflammatory
cells filling vessels (Figure 3C), and suggest that this
accounts, at least in part, for the reduced cerebral blood
flow. Vessel congestion has also been noted in MS
[12,14]. Vessel swelling is also observed in cEAE at 21-
23 days, which may occur as a compensatory response
to the vessel congestion.
Conclusion
In summary, cEAE mice have iron deposits around ves-
sels that can be seen by MRI and histochemistry. With
time, these iron stained vessels developed a greater aver-
age diameter than control vessels, perhaps in response
to inflammatory cell congestion leading to the observed
decreased cerebral blood flow. Mice with cEAE also
demonstrate increased astrogliosis and microgliosis, with
reactive microglia co-labeling with iron deposits. In con-
trast to the hypothesis proposing iron deposition
accounts for cellular inflammation, our data supports a
pathogenic mechanism whereby vascular inflammation
leads to alterations in CNS blood flow and iron deposi-
tion, not the other way around.
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